Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.230 (29.87%)
Aug 17, 2026, 11:22 AM EST
Nuo Therapeutics Revenue
Nuo Therapeutics had revenue of $1.77M in the quarter ending June 30, 2026, with 152.64% growth. This brings the company's revenue in the last twelve months to $5.20M, up 166.61% year-over-year. In the year 2025, Nuo Therapeutics had annual revenue of $3.31M with 142.72% growth.
Revenue (ttm)
5.20M
Revenue Growth
+166.61%
P/S Ratio
9.31
Revenue / Employee
520.00K
Employees
10
Market Cap
48.41M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.31M | 1.95M | 142.72% |
| Dec 31, 2024 | 1.37M | 756.65K | 124.34% |
| Dec 31, 2023 | 608.53K | 496.28K | 442.12% |
| Dec 31, 2022 | 112.25K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sangamo Therapeutics | 34.56M |
| Oncotelic Therapeutics | 250.00K |
| ZIVO Bioscience | 209.03K |
| Arch Biopartners | 113.25K |
| Provectus Biopharmaceuticals | 57.48K |
Nuo Therapeutics News
- 1 day ago - Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 8 months ago - Nuo Therapeutics initiated with a Buy at Roth Capital - TheFly
- 9 months ago - Nuo Therapeutics management to meet virtually with Roth Capital - TheFly
- 1 year ago - Nuo Therapeutics files $14M common stock offering - TheFly
- 1 year ago - Nuo Therapeutics enters Centrio distribution pact with Smith & Nephew - TheFly
- 1 year ago - Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewsWire
- 1 year ago - Nuo Therapeutics, PAM Health partner to advance access to wound healing therapy - TheFly